Assignee
WATSON LAB INC
US·29 granted patents·4 pending applications·1,062 citations·filing 1988–2021
Top patents by PatentIndex Score
33 records- 0196US4900552AMucoadhesive buccal dosage formsWATSON LAB INC·Filed 1988·Granted Feb 13, 1990·315 cites·10 claims
- 0295US5047244AMucoadhesive carrier for delivery of therapeutical agentWATSON LAB INC·Filed 1988·Granted Sep 10, 1991·252 cites·11 claims
- 0394US7087241B2Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapyWATSON LAB INC·Filed 2005·Granted Aug 8, 2006·25 cites·43 claims
- 0491US7799340B2Pharmaceutical compositions for lipophilic drugsWATSON LAB INC·Filed 2007·Granted Sep 21, 2010·7 cites·21 claims
- 0590US6974591B2Method for producing a controlled-release preparationWATSON LAB INC·Filed 2001·Granted Dec 13, 2005·59 cites·23 claims
- 0689US7921999B1Peelable pouch for transdermal patch and method for packagingWATSON LAB INC·Filed 2006·Granted Apr 12, 2011·58 cites·22 claims
- 0789US5637313AChewable dosage formsWATSON LAB INC·Filed 1994·Granted Jun 10, 1997·156 cites·29 claims
- 0887US7303763B2Compositions for conjugated estrogens and associated methodsWATSON LAB INC·Filed 2003·Granted Dec 4, 2007·52 cites·22 claims
- 0985US7985419B1Divisible tablet and associated methodsWATSON LAB INC·Filed 2006·Granted Jul 26, 2011·5 cites·49 claims
- 1082US7988995B1Pharmaceutical compositions for lipophilic drugsWATSON LAB INC·Filed 2002·Granted Aug 2, 2011·9 cites·6 claims
- 1181US7081249B2Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapyWATSON LAB INC·Filed 2003·Granted Jul 25, 2006·9 cites·39 claims
- 1281US7029694B2Compositions and methods for transdermal oxybutynin therapyWATSON LAB INC·Filed 2002·Granted Apr 18, 2006·15 cites·62 claims
- 1380US7081251B2Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapyWATSON LAB INC·Filed 2003·Granted Jul 25, 2006·8 cites·22 claims
- 1480US7081250B2Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapyWATSON LAB INC·Filed 2003·Granted Jul 25, 2006·8 cites·22 claims
- 1580US7081252B2Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapyWATSON LAB INC·Filed 2003·Granted Jul 25, 2006·8 cites·24 claims
- 1678US6251866B1Conjugates targeted to the interleukin-2 receptorWATSON LAB INC·Filed 1998·Granted Jun 26, 2001·44 cites·27 claims
- 1776US7838029B1Mirtazapine solid dosage formsWATSON LAB INC·Filed 2004·Granted Nov 23, 2010·6 cites·4 claims
- 1875US7938265B2Medicament dispenser and methodWATSON LAB INC·Filed 2009·Granted May 10, 2011·7 cites·27 claims
- 1973US9611068B2Frangible shipping carton and associated methodsWATSON LAB INC·Filed 2016·Granted Apr 4, 2017·1 cites·18 claims
- 2071US8038008B2Medicament dispenser and associated methodsWATSON LAB INC·Filed 2005·Granted Oct 18, 2011·3 cites·3 claims
- 2170US7802682B2Systems for increasing compliance with a medicament treatment regimeWATSON LAB INC·Filed 2007·Granted Sep 28, 2010·2 cites·8 claims
- 2269US8911773B2Peelable pouch for transdermal patch and method for packagingWATSON LAB INC·Filed 2013·Granted Dec 16, 2014·4 cites·26 claims
- 2367US7946461B2Ampoule opener and associated methodsWATSON LAB INC·Filed 2006·Granted May 24, 2011·9 cites·13 claims
- 2459US11820776B2Process for the preparation of Remimazolam and solid state forms of Remimazolam saltsWATSON LAB INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 2558US9422079B2Frangible shipping carton and associated methodsWATSON LAB INC·Filed 2015·Granted Aug 23, 2016·0 cites·9 claims
- 2656US9259388B2Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositionsWATSON LAB INC·Filed 2013·Granted Feb 16, 2016·0 cites·20 claims
- 2755US2008031932A1Transdermal atomoxetine formulations and associated methodsWATSON LAB INC·Filed 2006·Application pending·0 cites
- 2849US2021244729A1Novel crystalline forms of selinexor and process for their preparationWATSON LAB INC·Filed 2021·Application pending·0 cites
- 2949US2011046115A1Mirtazapine Solid Dosage FormsWATSON LAB INC·Filed 2010·Application pending·0 cites
- 3048US2007065494A1Formulations and Methods for Enhancing the Transdermal Penetration of a DrugWATSON LAB INC·Filed 2006·Application pending·0 cites
- 3146US11034697B2Process for the preparation of Remimazolam and solid state forms of Remimazolam saltsWATSON LAB INC·Filed 2018·Granted Jun 15, 2021·0 cites·20 claims
- 3245US10993943B2Crystalline forms of selinexor and process for their preparationWATSON LAB INC·Filed 2018·Granted May 4, 2021·0 cites·20 claims
- 3329US11149017B2Solid state forms of apalutamideWATSON LAB INC·Filed 2017·Granted Oct 19, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when WATSON LAB INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →